TREATMENT OF ADULT JUVENILE IDIOPATHIC ARTHRITIS PATIENTS WITH TNF BLOCKERS AND EFFECT OF SWITCHING TO A SECOND ANTI-TNF AGENT

被引：0
|
作者：
Jarosova, K. [1 ]
Chroust, K. [2 ]
Buresova, L. [2 ]
Vencovsky, J. [1 ]
机构：
[1] Inst Rheumatol, Prague, Czech Republic
[2] Inst Biostat & Anal, Brno, Czech Republic
来源：
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY | 2010年 / 16卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S14 / S14
页数：1
相关论文
共 50 条
  • [31] Effects of anti-TNF therapy on glucose metabolism in patients with ankylosing spondylitis, psoriatic arthritis or juvenile idiopathic arthritis
    Pires da Silva, Barbara Santos
    Bonfa, Eloisa
    Bertacini de Moraes, Julio Cesar
    Schain Saad, Carla Goncalves
    de Medeiros Ribeiro, Ana Cristina
    Goncalves, Celio Roberto
    de Carvalho, Jozelio Freire
    BIOLOGICALS, 2010, 38 (05) : 567 - 569
  • [32] Secukinumab Is a Promising Treatment for Patients with Juvenile Enthesitis Related Arthritis Nonresponsive to Anti-TNF Treatment
    Foeldvari, Ivan
    Baer, Jean
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [33] Drug Survival of Second Biologic DMARD Therapy in Patients with Rheumatoid Arthritis: Comparison of a Second Anti-TNF with a Second Non-Anti-TNF after Discontinuation of a First Anti-TNF
    Wilke, T.
    Mueller, S.
    Majer, I.
    Heisen, M.
    Fuchs, A.
    Maywald, U.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [34] Risk of new-onset uveitis in patients with juvenile idiopathic arthritis treated with anti-TNFα agents
    Saurenmann, R. K.
    Levin, A. V.
    Feldman, B. M.
    Laxer, R. M.
    Schneider, R.
    Silverman, F. D.
    JOURNAL OF PEDIATRICS, 2006, 149 (06): : 833 - 836
  • [35] Predictors of the Need for Anti-TNF Alpha Drugs in Patients With Juvenile Idiopathic Arthritis-Associated Uveitis
    Yildirim, Deniz Gezgin
    Belder, Nuran
    Ozdemir, Huseyin Baran
    Bakkaloglu, Sevcan A.
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2025, 28 (01)
  • [36] OUTCOMES AND ECONOMIC IMPACT OF SWITCHING FROM ANTI-TNF TO ANTI-TNF THERAPY COMPARED WITH SWITCHING FROM ANTI-TNF TO VEDOLIZUMAB THERAPY IN PATIENTS WITH IBD
    Chiorean, Michael V.
    Afzali, Anita
    Zhou, Zhou
    Macaulay, Dendy
    Rizzo, Joanne
    Skup, Martha
    Wang, Anthony
    GASTROENTEROLOGY, 2017, 152 (05) : S591 - S591
  • [37] Efficacy of anti-TNF therapy in subgroups of systemic-onset juvenile idiopathic arthritis
    Russo, R. A.
    Katsicas, M. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 567 - 567
  • [38] Sydenham's Chorea in a Girl with Juvenile Idiopathic Arthritis Treated with Anti-TNFα Therapy
    Cimaz, Rolando
    Gana, Simone
    Braccesi, Giulia
    Guerrini, Renzo
    MOVEMENT DISORDERS, 2010, 25 (04) : 511 - 514
  • [39] Risk of infections in rheumatoid arthritis patients switching from anti-TNF agents to rituximab, abatacept, or another anti-TNF agent, a retrospective administrative claims analysis
    Johnston, Stephen S.
    Turpcu, Adam
    Shi, Nianwen
    Fowler, Robert
    Chu, Bong-Chul
    Alexander, Kimberly
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2013, 43 (01) : 39 - 47
  • [40] MUCOSAL HEALING WITH A SECOND ANTI-TNF IN PATIENTS WITH ULCERATIVE COLITIS AFTER THE FAILURE OF THE PREVIOUS ANTI-TNF TREATMENT
    Papa, A.
    Pugliese, D.
    De Vitis, I.
    D'Aversa, F.
    Landi, R.
    Felice, C.
    Guidi, L.
    Armuzzi, A.
    Rapaccini, G. L.
    DIGESTIVE AND LIVER DISEASE, 2017, 49 : E203 - E203
12345